Cubist Systematic Strategies’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-255,444
Closed -$8.7M 3602
2024
Q3
$8.7M Buy
255,444
+221,498
+653% +$6.23M 0.05% 539
2024
Q2
$736K Sell
33,946
-136,548
-80% -$2.87M 0.01% 1926
2024
Q1
$3.78M Buy
170,494
+145,579
+584% +$3.55M 0.02% 1164
2023
Q4
$685K Sell
24,915
-26,465
-52% -$639K ﹤0.01% 2336
2023
Q3
$1.15M Sell
51,380
-93,072
-64% -$2.39M 0.01% 1783
2023
Q2
$3.68M Buy
144,452
+134,177
+1,306% +$3.25M 0.02% 1038
2023
Q1
$229K Sell
10,275
-178,335
-95% -$4.31M ﹤0.01% 3160
2022
Q4
$4.48M Buy
188,610
+16,290
+9% +$379K 0.03% 1118
2022
Q3
$2.86M Buy
172,320
+85,131
+98% +$1.92M 0.02% 1640
2022
Q2
$1.74M Buy
87,189
+5,296
+6% +$107K 0.01% 1991
2022
Q1
$2.26M Buy
+81,893
New +$2.34M 0.02% 1384
2021
Q4
Sell
-34,127
Closed -$1.58M 3651
2021
Q3
$1.58M Sell
34,127
-61,228
-64% -$2.67M 0.02% 1192
2021
Q2
$3.81M Buy
95,355
+29,951
+46% +$1.28M 0.04% 701
2021
Q1
$3.52M Sell
65,404
-58,234
-47% -$3.35M 0.05% 646
2020
Q4
$6.05M Buy
+123,638
New +$5.73M 0.08% 355
2020
Q3
Sell
-10,680
Closed -$277K 2658
2020
Q2
$277K Buy
+10,680
New +$266K ﹤0.01% 1886
2020
Q1
Sell
-12,668
Closed -$354K 2475
2019
Q4
$354K Buy
+12,668
New +$328K 0.01% 1742
2019
Q3
Sell
-48,393
Closed -$1.38M 2505
2019
Q2
$1.38M Buy
48,393
+13,320
+38% +$333K 0.03% 864
2019
Q1
$878K Buy
35,073
+9,213
+36% +$176K 0.03% 830
2018
Q4
$325K Sell
25,860
-4,709
-15% -$55.7K 0.02% 1228
2018
Q3
$292K Buy
+30,569
New +$337K 0.02% 1178

Other funds holding VCYT

Cubist Systematic Strategies's VCYT Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Veracyte (VCYT) in Q4 2024, closing a stake of 255,444 shares — an estimated $8.7M sold.

Cubist Systematic Strategies first reported a position in VCYT in Q3 2018 and held it in 21 quarters. The position peaked at $8.7M in Q3 2024. 318 funds tracked by Wall St. Rank hold VCYT as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining Veracyte position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 255,444 Veracyte shares in Q4 2024, an estimated $8.7M.
  • Cubist Systematic Strategies first reported a position in Veracyte in Q3 2018 and held it in 21 quarters.
  • Cubist Systematic Strategies's Veracyte position peaked at $8.7M in Q3 2024.
  • 318 funds tracked by Wall St. Rank held Veracyte as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.